Merck Signs Osteoporosis Deal with Japan Tobacco
By Taskin Ahmed
Pharma Deals Review: Vol 2008 Issue 100 (Table of Contents)
Published: 25 Sep-2008
DOI: 10.3833/pdr.v2008.i100.127 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Since Merck’s patent for Fosamax® (alendronate) expired in early 2008, the company has been seeking to fill the gap in its osteoporosis pipeline...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018